Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension

Official title: Effectiveness of Information-Motivation-Behavioral Skills -Based Intervention on Medication Adherence and Blood Pressure Control in North Ethiopia: A Cluster Randomized Controlled Trial

Run by Bahir Dar University · NCT07894068 · Data updated 2026-11-12

This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment230 (estimated)
SponsorBahir Dar University
Academic / other
Locations8 sites (Ādēt and 7 other locations)
StatusRecruiting
StartedJune 25, 2026
Main results expectedMarch 25, 2027
Study endsMay 25, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07894068 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with hypertension, on antihypertensive medication for at least 6 months, and identified as having poor medication adherence.

Probably not a fit

Patients with severe comorbidities or conditions preventing participation may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-methods study uses a cluster randomized design in eight public hospitals in North Ethiopia to test whether an IMB Model-guided health literacy intervention improves antihypertensive medication adherence compared with usual care. Hospitals are assigned to either the IMB intervention or usual care; participants are adults with hypertension and documented non-adherence. The primary outcome is medication adherence, with secondary outcomes including blood pressure control and hypertension self-management measures. A qualitative component explores participants’ experiences and contextual factors influencing adherence. The intervention provides information, motivation, and behavioral skills to support adherence and self-management, delivered in addition to standard care.

Why it matters

Potential benefit: If successful, the intervention could improve medication adherence and blood pressure control among adults with hypertension, potentially reducing cardiovascular risk.

How similar studies have gone: Prior studies in behavioral-health education suggest IMB-based approaches can improve adherence, though context-specific evidence in hypertension and low-resource settings is limited and this trial adds new data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 18 years and above.
2. Documented diagnosis of hypertension (BP ≥140/90)
3. ≥6 months on antihypertensive medication (this duration ensures stabilization of treatment regimens and allows reliable assessment of persistent medication adherence behavior and blood pressure outcomes).
4. Identified as having poor medication adherence

Exclusion Criteria:

1\. Severe comorbidities that limit life expectancy or participation

Where it's running

  • Adet Primary Hospital
    Ādēt, Ethiopia
    Recruiting
  • Adis Alem Primary Hospital
    Ādīs ‘Alem, Ethiopia
    Recruiting
  • Adiss alem
    Bahir Dar, Ethiopia
    Recruiting
  • Felehiwote
    Bahir Dar, Ethiopia
    Recruiting
  • Tibebe Ghion
    Bahir Dar, Ethiopia
    Recruiting
  • Durbete Primary Hospital
    Gurbetē, Ethiopia
    Recruiting
Show 2 more locations
  • Liben Hospita
    Līben, Ethiopia
    Recruiting
  • Merawi Hospital
    Mēch’a, Ethiopia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.